I have been following this stock for the past one week. The stock has been consolidating around the $0.010 – $0.02 range for one month and with some positive news flow coming in the past one week the stock is seeing trading volumes rise and today it was up 20% at $0.012 with thrice its average volumes. I feel the consolidation phase is over and this could be the early signs of a breakout to higher levels.
Here is a brief analysis of Patient Access Solutions, Inc. and why I feel the company could move up from its current levels.
Patient Access Solutions, Inc. (PASO.PK) is a Healthcare Solutions Company which has created a formidable array of technology, resources and allies to enable it to become an agent of radical change in what has traditionally been a slowly evolving healthcare information technology environment.
The Company’s products are designed to allow health care providers an easy migration to the EMR environment. Among these products are D-PAS, which is a state-of-the-art digital pen and paper technology based on Anoto technology, used to capture hand written information into digital forms and EMR systems and PAS Data Center, which is a terminal solution that allows health care providers to quickly and easily determine benefit eligibility. Patient Access Solutions, Inc. was founded in 2006 and is based in Hauppauge, New York.
Growth Through Strategic Alliances
Patient Access Solutions, Inc. entered into a partnership with iMedicor. The partnership will provide a complementary synergy of combined products and services that will enable enhanced information exchange capabilities by integrating the iMedicor portal with Patient Access Solution’s digital pen technology for the home healthcare industry and robust HIPAA transaction processing and reporting platform.
Being able to develop a mutually beneficial recurring revenue business model creates a win-win situation for both organizations. The Alliance’s first opportunity, a 5,000 member healthcare provider group, has entered its implementation phase and scheduled to be live by Q4, 2010. Conservative projections estimate recurring gross annual revenue of over $1,000,000 throughout the PASO user base.
Recently, the Board concluded that there are potential partnerships which will provide PASO and its shareholders with the best options in growing the business. The Company already has strategic partnerships with MedLink, Catrel AB and Anoto. Patient Access Solution plans to enter into many such strategic alliances, which will enable PASO to grow revenues significantly and add to shareholder value.
Opportunity From The Launch Of The National Health Information Exchange
A major step for the Company will be the highly anticipated launch of the National Health Information Exchange which is expected to go a long way in supporting and making a reality of the National Healthcare Communication Network. With iMedicor’s ClearLobby platform, an additional revenue driver and value added solution to users can be provided through the recently announced National health information exchange and the National Healthcare Communications Network (NHCN). This has the potential to substantially jack-up PASO’s revenues.
Significant Revenue Generation Opportunity
The Company has developed its sales pipeline of over 14 opportunities that management believes, will be valued at $20 million dollars in annual recurring revenue, based on the potential of licensed users of the products. In total, Patient Access Solutions intends to deploy its products to approximately 19,975 home healthcare workers and 2,000 healthcare providers. PASO is well positioned to execute on a majority of these opportunities and are considering additional strategic relationships that would add to its current revenue targets along with PASO’s current healthcare provider and hospital base.
Patient Access Solutions is well positioned to leverage its state-of-the-art technology and strategic partnerships to deliver strong results in the coming quarters. Also, the launch of the National health information exchange will benefit the company tremendously. I believe there is significant value in the stock and the current up move with good volumes could be the breakout that we all have been waiting for.
